In the remaining CSF AD biomarker negative participants, the combination of NFL and sAβPPβ still distinguished SSVD from controls with high diagnostic accuracy (AUROC 0.885, 95% CI: 0.804–0.944, p < 0.001). The gene discussed is NEFL; the disease is Alzheimer disease.